Sitagliptin After Ischemic Stroke in Type 2 Diabetic Patients: A Nationwide Cohort Study

The cerebrovascular safety and efficacy of sitagliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus (T2DM) with ischemic stroke remains uncertain. The aim of this study was to assess the efficacy and safety of sitagliptin in patients with T2DM with recent ischemic s...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Medicine (Baltimore)
Egile Nagusiak: Chen, Dong-Yi, Wang, Szu-Heng, Mao, Chun-Tai, Tsai, Ming-Lung, Lin, Yu-Sheng, Su, Feng-Chieh, Chou, Chung-Chuan, Wen, Ming-Shien, Wang, Chun-Chieh, Hsieh, I-Chang, Hung, Kuo-Chun, Cherng, Wen-Jin, Chen, Tien-Hsing
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wolters Kluwer Health 2015
Gaiak:
5300
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4617065/
https://ncbi.nlm.nih.gov/pubmed/26181549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000001128
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak